Search clinical trials for: Endothelin-3
Total 18362 results
-
Gilead SciencesCompleted
-
Samsung Medical CenterGlaxoSmithKlineNot yet recruiting
-
GlaxoSmithKlineTerminatedHypertensionSpain, Germany, Korea, Republic of, Canada, Japan, Netherlands, United Kingdom, Czechia, United States, China, Austria, Israel, Argentina, Russian Federation, Mexico, Saudi Arabia
-
University of California, Los AngelesNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHuman Papillomavirus | CIN 3 | CIN 2United States
-
NHS Greater Glasgow and ClydeKing's College London; University of Oxford; Royal Free Hospital NHS Foundation... and other collaboratorsCompletedMicrovascular AnginaUnited Kingdom
-
Indonesia UniversityRecruitingBurn Degree Second | Burn Degree ThirdIndonesia
-
Massachusetts General HospitalDana-Farber Cancer Institute; Brigham and Women's Hospital; AbbottCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Mersin UniversityRecruiting
-
Centre Hospitalier Universitaire de NiceCompletedAdult Chronic Haemodialysis Patients Since at Least 3 MonthsFrance
-
ActelionActive, not recruitingPulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)United States, Japan, Taiwan, Turkey, Canada, China, Germany, Spain, Italy, Malaysia, Hungary, Russian Federation, Brazil, Australia, Bulgaria, Czechia, Mexico, Poland, South Africa
-
University of EdinburghEncysive PharmaceuticalsUnknownProteinuria | Chronic Kidney Disease | Blood PressureUnited Kingdom
-
PfizerCompletedPulmonary Arterial Hypertension
-
Indiana UniversityTerminatedVascular Function, Endothelin, and Inflammation in Pre-diabetic Obesity Versus Lean Healthy ControlsObesity | Pre-diabetesUnited States
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
3-C Institute for Social DevelopmentCompleted
-
3-C Institute for Social DevelopmentCompletedSubstance-Related DisordersUnited States
-
Centre Oscar LambretUniversité Lille 3Completed
-
Linkoeping UniversityArmauer Hansen Research Institute, Ethiopia; University of GondarCompleted
-
Mahidol UniversityBayer; Chulalongkorn University; Bumrungrad International HospitalCompletedCarcinoma, HepatocellularThailand
-
Linkoeping UniversityKalmar County Hospital; University of GondarCompleted
-
Assistance Publique - Hôpitaux de ParisFondation Plan Alzheimer; Naturalia & BiologiaRecruitingAlzheimer Disease | Subjective Cognitive ImpairmentFrance
-
Rambam Health Care CampusThe Baruch Padeh Medical Center, PoriyaRecruitingCOVID-19 | MIS-C Associated With COVID-19Israel
-
University of North Carolina, Chapel Hill3-C Family ServicesCompleted
-
ASLAN PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Australia, Singapore
-
GeropharmCompletedPharmacokinetics | BioequivalenceRussian Federation
-
University Hospital, Strasbourg, FranceUnknown
-
UCB Japan Co. Ltd.CompletedEpilepsy | Partial Onset SeizuresJapan
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
Changhua Christian HospitalTaipei Veterans General Hospital, TaiwanCompletedPhysiological Effect of TCC on Glucose MetabolismTaiwan
-
Rabin Medical CenterOmega 3 GalileeRecruiting
-
3-C Institute for Social DevelopmentCompletedSocial Skills | Trauma, Psychological | Family DysfunctionalUnited States
-
3-C Institute for Social DevelopmentCompletedDiabetes Mellitus, Type 1United States
-
3-C Institute for Social DevelopmentCompletedRenal Insufficiency, ChronicUnited States
-
Gomel State Medical UniversityRecruiting
-
NovartisNovartis VaccinesCompleted
-
Novartis VaccinesCompletedSeasonal Influenza, VaccineGermany
-
Michael PfeilstöckerCelgene CorporationCompletedMyelodysplastic SyndromesAustria
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Sir Run Run Shaw HospitalCompleted
-
Corregene Biotechnology Co., LtdRecruitingCervical Cancer | Anal Cancer | Head and Neck CancersChina
-
Allievex CorporationCompletedMucopolysaccharidosis Type IIIB | Mucopolysaccharidosis Type 3 B | MPS III B | MPS 3 BUnited States, Spain, Turkey, Taiwan, Australia, Colombia, Germany, United Kingdom
-
St George's, University of LondonCompletedCKd Patients With Stage 3 and 4
-
Memorial Sloan Kettering Cancer CenterChugai Pharma USARecruitingPrimary Extra-cranial Solid Tumor | Recurrent or Refractory Glypican 3 (GPC3)United States
-
Amsterdam UMC, location VUmcUnknownPulmonary Arterial HypertensionNetherlands
-
October 6 UniversityCompletedPeriodontitis (Stage 3)Egypt
-
Holbaek SygehusOdense University HospitalUnknownStability of Clavicular Fractures Within the First 3 WeeksDenmark
-
Eisai Inc.CompletedInsomnia DisorderUnited States, Canada, Finland, Germany, Italy, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Romania, Spain